Skip to search formSkip to main contentSkip to account menu

eletriptan

Known as: (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole, Eletriptanum, eletriptan [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

16 relations
Angina Pectoris, VariantCerebral Arterial Vasoconstriction [PE]Cerebrovascular accidentDrug Allergy

Broader (3)

PyrrolidinesSerotonin AgonistsTryptamines

Narrower (1)

Relpax

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Anticipated benefits and surprising effects of daclizumab in multiple sclerosis
2007
2007
Patient satisfaction with eletriptan in the acute treatment of migraine in primary care
Objective:  The efficacy of triptans for acute migraine has been well established in clinical trials but not in primary care… 
2005
2005
Patient preference for eletriptan 80 mg versus subcutaneous sumatriptan 6 mg: results of a crossover study in patients who have recently used subcutaneous sumatriptan
This current randomized, open‐label, crossover study evaluated preference for oral eletriptan 80 mg compared with subcutaneous… 
Review
2004
Review
2004
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).
2004
2004
Nitrergic and glutamatergic neuronal mechanisms at the trigeminovascular first-order synapse
2004
2004
Cost effectiveness of oral triptan therapy: a trans-national comparison based on a meta-analysis of randomised controlled trials
Objective: The objective of this study was to appraise the relative cost effectiveness of oral triptan therapy in the management… 
2004
2004
Eletriptan for the acute treatment of migraine: results of bridging a Japanese study to Western clinical trials
SUMMARY Objective: To compare the efficacy, safety and tolerability of eletriptan (20,40 and 80 mg) to placebo when given to… 
2003
2003
Efficacy of Eletriptan in Migraineurs With Persistent Poor Response to Nonsteroidal Anti‐inflammatory Drugs
Background/Objective.—Nonsteroidal anti‐inflammatory drugs continue to be one of the most widely used therapies for migraine, but… 
Review
2001
Review
2001
Comparative aspects of triptans in treating migraine.
Review
2000
Review
2000
Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan.
5. Spierings ELH. Therapeutic gain: a critique. Headache 1999;39:517– 518. Letter. 6. Tfelt-Hansen P, Teall J, Rodriguez F, et al… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)